Sign Up to like & get
recommendations!
0
Published in 2020 at "British Journal of Cancer"
DOI: 10.1038/s41416-019-0711-3
Abstract: Background Recent studies have suggested that fatty acid oxidation (FAO) is a key metabolic pathway for the growth of triple negative breast cancers (TNBCs), particularly those that have high expression of MYC. However, the underlying…
read more here.
Keywords:
claudin low;
fatty acid;
myc;
multigenic program ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.epso16-b47
Abstract: Triple negative breast cancers (TNBC) are characterized by loss of expression of hormone receptors and decreased expression of the human epidermal growth factor receptor 2 (HER2). TNBC patients do not benefit from current targeted breast…
read more here.
Keywords:
low breast;
breast;
clbc;
breast cancer ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2017 at "JCI insight"
DOI: 10.1172/jci.insight.94296
Abstract: The complex signaling networks of the tumor microenvironment that facilitate tumor growth and progression toward metastatic disease are becoming a focus of potential therapeutic options. The chemokine IL-8 is overexpressed in multiple cancer types, including…
read more here.
Keywords:
breast cancer;
cancer;
claudin low;
mesenchymalization ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancer Cell International"
DOI: 10.1186/s12935-021-01784-4
Abstract: Background MicroRNAs are a class of non-coding RNAs that regulate gene expression through binding to mRNAs and preventing their translation. One family of microRNAs known as the miR-200 family is an important regulator of epithelial…
read more here.
Keywords:
mir 200s;
tumor cells;
expression;
mammary tumor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.15829
Abstract: Claudin-low breast cancer is a relatively rare breast cancer subtype. These cancers are typically ER−/PR−/HER2− and express high levels of mesenchymal genes as well as genes associated with inflammation, angiogenesis and stem cell function. In…
read more here.
Keywords:
claudin low;
mir 200;
mir 200c;
growth ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Iranian Journal of Basic Medical Sciences"
DOI: 10.22038/ijbms.2019.35674.8500
Abstract: Objective(s): The growing trend of research demonstrates that dynamic expression of two metastasis repressor classes (metastasis suppressor genes and anti-metastatic miRNA) has a close relationship with tumor invasion and metastasis. Using different strategies, it was…
read more here.
Keywords:
claudin low;
metastasis;
brms1;
cell ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1020729
Abstract: Background In bladder and breast cancer, the claudin-low subtype is widely identified, revealing a distinct tumor microenvironment (TME) and immunological feature. Although we have previously identified individual claudin members as prognostic biomarkers in clear cell…
read more here.
Keywords:
cell;
cell carcinoma;
low subtype;
clear cell ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2021 at "Cancers"
DOI: 10.3390/cancers13040906
Abstract: Simple Summary Here, we identified and characterized a claudin-low subtype of high-grade serous ovarian cancer. This rare variant of undifferentiated neoplasm shares transcriptional features with the homonym subtype of breast cancer, including low epithelial differentiation,…
read more here.
Keywords:
grade serous;
cell;
high grade;
claudin low ... See more keywords